Glenmede Trust CO Na Elanco Animal Health Inc Transaction History
Glenmede Trust CO Na
- $19.1 Billion
- Q4 2024
A detailed history of Glenmede Trust CO Na transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Glenmede Trust CO Na holds 32,982 shares of ELAN stock, worth $356,535. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,982
Previous 37,938
13.06%
Holding current value
$356,535
Previous $556,000
28.24%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding ELAN
# of Institutions
439Shares Held
448MCall Options Held
1.16MPut Options Held
1.12M-
Dodge & Cox San Francisco, CA83.2MShares$899 Million0.63% of portfolio
-
Primecap Management CO Pasadena, CA51.2MShares$553 Million0.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.8MShares$527 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$252 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A620.4MShares$221 Million11.79% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $5.13B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...